ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects
Clinical trial NCT03687632 · COMPLETED
Trial details
- NCT number
- NCT03687632
- Sponsor
- Noveome Biotherapeutics, formerly Stemnion
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-10
- Primary completion
- 2020-08-18
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.